Literature DB >> 1079684

Tissue distribution of metoprolol-(3-h) in the mouse and the rat.

N O Bodin, K O Borg, R Johnansson, C H Ramsay, I Skänberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1079684     DOI： 10.1111/j.1600-0773.1975.tb03328.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  13 in total

Review 1.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

2.  Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.

Authors:  A J WOOD
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

3.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.

Authors:  B G Hansson; J F Dymling; H Hedeland; U L Hulthén
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

4.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

5.  Pharmacokinetics of mepindolol sulphate in animals.

Authors:  W Krause; G Kühne; U Täuber
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

6.  Effect of acute and chronic beta-blockade on carbon dioxide sensitivity in normal man.

Authors:  P F Hutchinson; R N Harrison
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

7.  The pharmacokinetics of metoprolol and its metabolites in dialysis patients.

Authors:  K U Seiler; K J Schuster; G J Meyer; W Niedermayer; O Wassermann
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.

Authors:  D W Costain; A R Green
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

Review 9.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Presence of beta-adrenoreceptors in the hypothalamus; their importance for the pressor response to hypothalamic stimulation.

Authors:  A Philippu; E Kittel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.